PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury
Pulmonary fibrosis is a pathological fibrotic process affecting the lungs of five million people worldwide. The incidence rate will increase even more in the next years due to the long-COVID-19 syndrome, but a resolving treatment is not available yet and usually prognosis is poor. The emerging role...
Main Authors: | Jean Piero Margaria, Lucia Moretta, Jose Carlos Alves-Filho, Emilio Hirsch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/4/756 |
Similar Items
-
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
by: Jincheng Wang, et al.
Published: (2022-01-01) -
Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway
by: Jieting Peng, et al.
Published: (2023-02-01) -
Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
by: Jiang Li, et al.
Published: (2023-09-01) -
Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
by: Ziyi Wang, et al.
Published: (2022-12-01) -
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
by: Hailong Li, et al.
Published: (2021-01-01)